AVANIR PHARMACEUTICALS
Central Nervous System Pharmaceutical Research and Development/Pharmaceutical Sales
Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.
Income by year
Filings
| Filing | Client | Income | Expenses |
|---|---|---|---|
|
4th Quarter - Report 4th Quarter 2016
|
AVANIR PHARMACEUTICALS | — income | $80,000 expenses |
|
3rd Quarter - Report 3rd Quarter 2016
|
AVANIR PHARMACEUTICALS | — income | $80,000 expenses |
|
2nd Quarter - Amendment 2nd Quarter 2016
|
AVANIR PHARMACEUTICALS | — income | $110,000 expenses |
|
2nd Quarter - Reportreplaced 2nd Quarter 2016
|
AVANIR PHARMACEUTICALS | — income | $110,000 expenses |
|
1st Quarter - Report 1st Quarter 2016
|
AVANIR PHARMACEUTICALS | — income | $180,000 expenses |
Clients
Everyone this filer has reported for, with the reports filed and the income they disclose.
| Client | Reports | Income |
|---|---|---|
| AVANIR PHARMACEUTICALS | 19 | — |
Lobbyists
Everyone named on this filer's reports, with the government post they most recently disclosed here.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CHRISTINE D'ORSIE | Director of Advocacy |
| CATHERINE DRATZ FERGUSON | — |
| CRYSTAL LYNN VANUCH | Head of Government Affairs |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.